Radiofrequency Ablation Versus Lateralization as Office-Based Procedures for Bilateral Inferior Turbinate Hypertrophy
1 other identifier
interventional
54
1 country
1
Brief Summary
: Patient Information Sheet and Informed Consent Form PATIENT INFORMATION SHEET AND INFORMED CONSENT FORM (for adult subjects and interventional studies)
- You will first be examined on your nose condition by using a scope.
- The size of your turbinates will be documented.
- You will be given a set of questionnaire regarding your nose condition to fill up
- Your nose will be sprayed on either side, 2 puffs each of the decongestant spray.
- You will be given painkiller via injections over the inner side of your nose
- Cotton with medication will be inserted into your nose for 5 minutes
- Either 1 of the procedures will b performed
- After the procedure, you will be monitored for 15 minutes
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Nov 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 17, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 17, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
June 17, 2022
CompletedFirst Submitted
Initial submission to the registry
July 16, 2026
CompletedFirst Posted
Study publicly available on registry
August 19, 2026
CompletedAugust 19, 2026
August 1, 2026
1.2 years
July 16, 2026
August 13, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Primary outcome measures
1\. Change in Nasal Obstruction Symptom Evaluation (NOSE) Score Description: The total NOSE score ranges from a minimum of 0 to a maximum of 100 points on a scale, where higher scores indicate worse nasal obstruction (a more severe symptom burden). A successful outcome is defined as a reduction in score from a moderate/extreme level to a mild level. Measure Type: Mean Unit of Measure: score on a scale (0-100) Time Frame: Baseline, 1 week, 1 month, 3 months and 6 months post-procedure
Baseline, 1 week, 1 month, 3 months and 6 months post-procedure
Secondary Outcomes (1)
Secondary outcome measures
Baseline, 1 week, 1 month, 3 months, 6 months post-procedure
Study Arms (2)
Radiofrequency ablation
ACTIVE COMPARATORPatients with bilateral inferior turbinates hypertrophy who underwent radiofrequency ablation of inferior turbinates
Lateralization of inferior turbinates
ACTIVE COMPARATORPatients with bilateral inferior turbinates who underwent lateralization of inferior turbinates
Interventions
Both are office procedures that can be done in clinic and we would like to determine the effectiveness of both.
Lateralization of inferior turbinates with freer elevator
Eligibility Criteria
You may qualify if:
- Bilateral inferior turbinate hypertrophy, Grade 3 or 4 (25% Inferior Turbinate Classification System) Age more than 18 years NOSE score more than 30 On conventional pharmacological therapy for more than 3 months
You may not qualify if:
- Severe deviated nasal septum or caudal dislocation Nasal polyposis Nasal valve disorder Allergy or contraindication to Marcaine (bupivacaine) with adrenaline, or to Co-Phenylcaine
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Goh Liang Chyelead
Study Sites (1)
Tengku Ampuan Rahimah Hospital
Klang, Selangor, 41200, Malaysia
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Liang Chye Goh, MBBS, MS ORL HNS
University of Malaya
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- * Patients will be allocated a number on registering for the research, such as (001,002,003,…180). By using the research randomixer online, participants will be randomly assigned to either group 1 or group 2. * Photographs of the inferior turbinates will be taken before and after procedures during each visit. The photographs will be assessed by 3 different surgeons, and the surgeons will not be informed on whether it is pre or post procedure. (outcome assessment blinding) * There should be no breaking of the randomization code as the end point accessors are the patients themselves.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Clinical Associate Professor
Study Record Dates
First Submitted
July 16, 2026
First Posted
August 19, 2026
Study Start
November 17, 2020
Primary Completion
January 17, 2022
Study Completion
June 17, 2022
Last Updated
August 19, 2026
Record last verified: 2026-08
Data Sharing
- IPD Sharing
- Will not share
to protect patients' anonymity and privacy